Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1607 PMEDAPSummary: PMEDAP is a potent inhibitor of human immunodeficiency virus replication. -
BA1608 B220Summary: B220 is an inhibitor. -
BA1609 SB-734117Summary: SB-734117 is a human cytomegalovirus replication inhibitor. -
BA1610 FiztasovimabSummary: Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ monoclonal antibody with anti-human cytomegalovirus (h) activity. -
BA1612 NITD008Summary: NITD008 is a potent and selective flavivirus inhibitor. -
BA1613 MosnodenvirSummary: Mosnodenvir (JNJ-1802) is a pan-serotypic dengue antiviral that has a high barrier to resistance, is safe and well tolerated. -
BA1614 QL47Summary: QL47 is a broad-spectrum antiviral active molecule that inhibits dengue and other RNA viruses. -
BA1615 KIN1408Summary: KIN1408 is an agonist of the RIG-1-like receptor pathway. -
BA1616 NITD-688Summary: NITD-688 is an orally active pan-serotypic inhibitor of dengue virus (denguevirus) protein. -
BA1617 HeE1-2TyrSummary: HeE1-2Tyr is a pyridobenzothiazole, a flavivirus RNA-dependent RNA polymerase inhibitor.

